Context Therapeutics Inc (CNTX)

Context Therapeutics Inc (CNTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $28.9M; returns 1 day +1.6%, 1 week -1.9%, 1 year -81.3%.

Context Therapeutics Inc. (CNTX) is a clinical-stage biopharmaceutical company focused on developing T cell engaging (TCE) bispecific antibodies for the treatment of solid tumors.

Groups CNTX belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Bispecific Antibodies
• Oncology
• Cancer Therapeutics
• Antibody Therapeutics
• Healthcare
• Clinical Stage
• Immunotherapy
• Women's Health
• Life Sciences

CNTX financial model: income statement, cash flow and balance sheet